VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q87364644 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000224.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q87364644‏
024 ‎‡a 0000-0002-2822-4466‏ ‎‡2 orcid‏
024 ‎‡a 56557100900‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q87364644‏
100 0 ‎‡a Diego de Miguel-Pérez‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Diego de Miguel-Pérez‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's Association of circulating tumour cells with early relapse and 18F-fluorodeoxyglucose positron emission tomography uptake in resected non-small-cell lung cancers.‏
670 ‎‡a Author's Circulating tumor cells criteria‏
670 ‎‡a Author's Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients‏
670 ‎‡a Author's Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection‏
670 ‎‡a Author's Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents‏
670 ‎‡a Author's Exchange of cellular components between platelets and tumor cells: impact on tumor cells behavior‏
670 ‎‡a Author's Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy‏
670 ‎‡a Author's Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prognosis in metastatic colorectal cancer patients‏
670 ‎‡a Author's Improving extracellular vesicles visualization: From static to motion‏
670 ‎‡a Author's Interfering with endolysosomal trafficking enhances release of bioactive exosomes‏
670 ‎‡a Author's Liquid biopsy beyond of cancer: Circulating pulmonary cells as biomarkers of COPD aggressivity‏
670 ‎‡a Author's Liquid biopsy tracking of lung tumor evolutions over time‏
670 ‎‡a Author's miRNA in situ hybridization in circulating tumor cells--MishCTC‏
670 ‎‡a Author's Post-Surgery Circulating Tumor Cells and AXL Overexpression as New Poor Prognostic Biomarkers in Resected Lung Adenocarcinoma‏
670 ‎‡a Author's Significance of EGFR Expression in Circulating Tumor Cells.‏
670 ‎‡a Author's Speeding tumor genotyping during the SARS-CoV-2 outbreak through liquid biopsy‏
909 ‎‡a (orcid) 0000000228224466‏ ‎‡9 1‏
909 ‎‡a (scopus) 56557100900‏ ‎‡9 1‏
919 ‎‡a associationofcirculatingtumourcellswithearlyrelapseand18ffluorodeoxyglucosepositronemissiontomographyuptakeinresectednonsmallcelllungcancers‏ ‎‡A Association of circulating tumour cells with early relapse and 18F-fluorodeoxyglucose positron emission tomography uptake in resected non-small-cell lung cancers.‏ ‎‡9 1‏
919 ‎‡a speedingtumorgenotypingduringthesarscov2outbreakthroughliquidbiopsy‏ ‎‡A Speeding tumor genotyping during the SARS-CoV-2 outbreak through liquid biopsy‏ ‎‡9 1‏
919 ‎‡a significanceofegfrexpressionincirculatingtumorcells‏ ‎‡A Significance of EGFR Expression in Circulating Tumor Cells.‏ ‎‡9 1‏
919 ‎‡a postsurgerycirculatingtumorcellsandaxloverexpressionasnewpoorprognosticbiomarkersinresectedlungadenocarcinoma‏ ‎‡A Post-Surgery Circulating Tumor Cells and AXL Overexpression as New Poor Prognostic Biomarkers in Resected Lung Adenocarcinoma‏ ‎‡9 1‏
919 ‎‡a mirnainsituhybridizationincirculatingtumorcellsmishctc‏ ‎‡A miRNA in situ hybridization in circulating tumor cells--MishCTC‏ ‎‡9 1‏
919 ‎‡a liquidbiopsytrackingoflungtumorevolutionsovertime‏ ‎‡A Liquid biopsy tracking of lung tumor evolutions over time‏ ‎‡9 1‏
919 ‎‡a liquidbiopsybeyondofcancercirculatingpulmonarycellsasbiomarkersofcopdaggressivity‏ ‎‡A Liquid biopsy beyond of cancer: Circulating pulmonary cells as biomarkers of COPD aggressivity‏ ‎‡9 1‏
919 ‎‡a interferingwithendolysosomaltraffickingenhancesreleaseofbioactiveexosomes‏ ‎‡A Interfering with endolysosomal trafficking enhances release of bioactive exosomes‏ ‎‡9 1‏
919 ‎‡a improvingextracellularvesiclesvisualizationfromstatictomotion‏ ‎‡A Improving extracellular vesicles visualization: From static to motion‏ ‎‡9 1‏
919 ‎‡a extracellularvesiclemirnasasliquidbiopsybiomarkersfordiseaseidentificationandprognosisinmetastaticcolorectalcancerpatients‏ ‎‡A Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prognosis in metastatic colorectal cancer patients‏ ‎‡9 1‏
919 ‎‡a exosomalmirnaprofileascomplementarytoolinthediagnosticandpredictionoftreatmentresponseinlocalizedbreastcancerunderneoadjuvantchemotherapy‏ ‎‡A Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy‏ ‎‡9 1‏
919 ‎‡a exchangeofcellularcomponentsbetweenplateletsandtumorcellsimpactontumorcellsbehavior‏ ‎‡A Exchange of cellular components between platelets and tumor cells: impact on tumor cells behavior‏ ‎‡9 1‏
919 ‎‡a cooperativeandescapingmechanismsbetweencirculatingtumorcellsandbloodconstituents‏ ‎‡A Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents‏ ‎‡9 1‏
919 ‎‡a circulatingtumorcellsidentifyearlyrecurrenceinpatientswithnonsmallcelllungcancerundergoingradicalresection‏ ‎‡A Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection‏ ‎‡9 1‏
919 ‎‡a circulatingtumorcellscriteriacycarversusstandardrecistcriteriafortreatmentresponseassessmentinmetastaticcolorectalcancerpatients‏ ‎‡A Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients‏ ‎‡9 1‏
919 ‎‡a circulatingtumorcellscriteria‏ ‎‡A Circulating tumor cells criteria‏ ‎‡9 1‏
996 ‎‡2 NKC|mzk20231194679
996 ‎‡2 LC|n 2020066165
996 ‎‡2 LC|no2001046249
996 ‎‡2 ISNI|0000000499074594
996 ‎‡2 BNE|XX1252210
996 ‎‡2 NUKAT|n 2015147367
996 ‎‡2 LC|ns2023000779
996 ‎‡2 SUDOC|277001633
996 ‎‡2 DNB|1052820417
996 ‎‡2 LC|no2010030428
996 ‎‡2 ISNI|0000000420548591
996 ‎‡2 NTA|43403049X
996 ‎‡2 RERO|A023337830
996 ‎‡2 DNB|1056336072
996 ‎‡2 BNE|XX1574890
996 ‎‡2 BNE|XX1144993
996 ‎‡2 LC|n 2023250350
996 ‎‡2 LC|n 2013056751
996 ‎‡2 BNE|XX4579826
996 ‎‡2 BNE|XX839195
996 ‎‡2 ISNI|0000000060319874
996 ‎‡2 CAOONL|ncf11870815
996 ‎‡2 LC|no2020012096
996 ‎‡2 ISNI|0000000418400651
996 ‎‡2 BNCHL|10000000000000000117353
996 ‎‡2 LC|n 2006056773
996 ‎‡2 PTBNP|432611
996 ‎‡2 BNE|XX1754328
996 ‎‡2 ISNI|0000000117739483
996 ‎‡2 ISNI|0000000359221361
996 ‎‡2 SUDOC|262917378
996 ‎‡2 DNB|119794748
996 ‎‡2 BNE|XX862433
996 ‎‡2 DNB|1217439803
996 ‎‡2 LC|n 82056650
996 ‎‡2 NTA|353893099
996 ‎‡2 LC|no2007084940
996 ‎‡2 LC|no2002030035
996 ‎‡2 LC|no2018023143
996 ‎‡2 BNE|XX1378056
996 ‎‡2 NUKAT|n 2021140920
996 ‎‡2 LC|no2018019569
996 ‎‡2 BNE|XX5106075
996 ‎‡2 RERO|A018449869
996 ‎‡2 BNE|XX4665252
996 ‎‡2 BNE|XX6350329
996 ‎‡2 LC|nb2013026041
996 ‎‡2 BNE|XX5106078
996 ‎‡2 LC|n 2018044918
996 ‎‡2 SUDOC|08602485X
996 ‎‡2 BNC|981058615254306706
996 ‎‡2 DNB|1122691920
996 ‎‡2 ISNI|0000000041495629
996 ‎‡2 LC|n 80066580
996 ‎‡2 LC|no2017148991
996 ‎‡2 BNCHL|10000000000000000070381
996 ‎‡2 BNE|XX4788443
996 ‎‡2 ISNI|0000000502698796
996 ‎‡2 BNF|12012341
996 ‎‡2 PLWABN|9811793232505606
996 ‎‡2 SUDOC|228923417
996 ‎‡2 BNC|981058599398106706
996 ‎‡2 BNC|981058620201006706
996 ‎‡2 DNB|124134955
996 ‎‡2 PLWABN|9812000438105606
996 ‎‡2 BNC|981058546962206706
996 ‎‡2 ISNI|0000000118234866
996 ‎‡2 SUDOC|069412537
996 ‎‡2 SUDOC|196901995
996 ‎‡2 BNE|XX1066870
996 ‎‡2 DNB|13252337X
996 ‎‡2 LC|no2016121896
996 ‎‡2 LC|n 85386283
996 ‎‡2 SUDOC|136533566
996 ‎‡2 ISNI|0000000381708926
996 ‎‡2 BNC|981058515269806706
996 ‎‡2 LC|no2021137142
996 ‎‡2 ARBABN|000042412
996 ‎‡2 ISNI|000000005495787X
996 ‎‡2 PTBNP|44233
996 ‎‡2 PLWABN|9813925062205606
996 ‎‡2 BNE|XX5232920
996 ‎‡2 RERO|A013535692
996 ‎‡2 VLACC|000045963
996 ‎‡2 SUDOC|221241647
996 ‎‡2 BNC|981058609430906706
996 ‎‡2 BNE|XX4660865
996 ‎‡2 BLBNB|000372093
996 ‎‡2 NTA|132855941
996 ‎‡2 BNE|XX5101895
996 ‎‡2 BNCHL|10000000000000000166367
996 ‎‡2 BNE|XX1395737
996 ‎‡2 LC|n 2009009756
996 ‎‡2 BNC|981061134112406706
996 ‎‡2 NTA|304136468
996 ‎‡2 SUDOC|24332264X
996 ‎‡2 BNE|XX5595431
996 ‎‡2 DNB|1190115786
996 ‎‡2 PTBNP|1543822
996 ‎‡2 ISNI|0000000114834426
996 ‎‡2 BNE|XX824314
996 ‎‡2 BNCHL|10000000000000000862412
996 ‎‡2 BNC|981058617146106706
996 ‎‡2 BNE|XX6335371
996 ‎‡2 LC|no2017158750
996 ‎‡2 BNE|XX1021643
996 ‎‡2 JPG|500089033
996 ‎‡2 DNB|1053393628
996 ‎‡2 ISNI|0000000059742288
996 ‎‡2 J9U|987007516873705171
996 ‎‡2 ISNI|0000000118645921
996 ‎‡2 BNC|981058514323806706
996 ‎‡2 SUDOC|124958176
996 ‎‡2 BNC|981058515891706706
996 ‎‡2 BNE|XX5433402
996 ‎‡2 BNF|12111225
996 ‎‡2 BNE|XX4926286
996 ‎‡2 SUDOC|268280800
996 ‎‡2 BNC|981058611721706706
996 ‎‡2 BNE|XX4941484
996 ‎‡2 BNE|XX1791384
996 ‎‡2 DNB|1057045268
996 ‎‡2 BNE|XX5807421
996 ‎‡2 LC|n 94007151
996 ‎‡2 LC|no2005002485
996 ‎‡2 BNE|XX975292
996 ‎‡2 ISNI|0000000061565911
996 ‎‡2 PTBNP|1810147
996 ‎‡2 BNC|981058617613906706
996 ‎‡2 DNB|1057215597
996 ‎‡2 PTBNP|1757558
996 ‎‡2 DNB|1159034338
996 ‎‡2 ISNI|0000000116104312
996 ‎‡2 BNE|XX1637626
996 ‎‡2 PTBNP|1875418
996 ‎‡2 PTBNP|469203
996 ‎‡2 ISNI|0000000046494473
996 ‎‡2 BNE|XX6241099
996 ‎‡2 ISNI|0000000121449999
996 ‎‡2 LC|no2012040268
996 ‎‡2 JPG|500241818
996 ‎‡2 BNE|XX5157729
996 ‎‡2 NII|DA0924147X
996 ‎‡2 LC|ns2023001013
996 ‎‡2 RERO|A020095595
996 ‎‡2 SUDOC|029497434
996 ‎‡2 DNB|1310631379
996 ‎‡2 NSK|000789943
996 ‎‡2 SUDOC|250685140
996 ‎‡2 BNCHL|10000000000000000057563
996 ‎‡2 DNB|1167808223
996 ‎‡2 BNE|XX4784047
996 ‎‡2 ISNI|0000000423090264
996 ‎‡2 LC|n 2009028103
996 ‎‡2 BNC|981058516884906706
996 ‎‡2 ISNI|0000000077158755
996 ‎‡2 SUDOC|232450498
996 ‎‡2 ISNI|0000000059517654
996 ‎‡2 DNB|105678735X
996 ‎‡2 ISNI|0000000358493621
996 ‎‡2 NSK|000242796
996 ‎‡2 BNE|XX1282192
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏